CJC-1295 and Ipamorelin: What US Patients Need to Know About Growth Hormone Peptides

What are CJC-1295 and Ipamorelin?

CJC-1295 and Ipamorelin belong to a class of peptides called growth hormone secretagogues (GHS). Rather than replacing growth hormone, they stimulate your pituitary gland to release more of it - working with your body's own regulatory systems rather than overriding them.

CJC-1295 is a growth hormone-releasing hormone (GHRH) analogue. It binds to GHRH receptors in the pituitary and signals the gland to produce and release growth hormone. The version most commonly used clinically (CJC-1295 without DAC) has a shorter half-life and produces a more pulsatile, natural-feeling GH release. The version with DAC (Drug Affinity Complex) has a much longer half-life - producing a sustained, low-level stimulation that some practitioners prefer for convenience.

Ipamorelin is a growth hormone-releasing peptide (GHRP) that works through a different receptor pathway - the ghrelin receptor. It triggers a separate growth hormone release signal and is known for producing a clean pulse with minimal effect on cortisol or prolactin (a common side effect issue with older GHRPs like GHRP-6 and GHRP-2).

Why are they usually combined? CJC-1295 and Ipamorelin work through complementary pathways - GHRH and ghrelin receptors respectively. When combined, they produce a synergistic release of growth hormone that is larger than either would produce alone, while remaining within physiological patterns that the body regulates naturally.

What are they prescribed for?

At physician-supervised clinics in the US, CJC-1295/Ipamorelin combinations are typically prescribed for:

• Healthy aging and body composition - supporting lean mass maintenance and reducing the body fat accumulation that often accompanies age-related GH decline
• Recovery and tissue repair - some practitioners use GH secretagogues to support healing from injury, surgery, or intense training
• Sleep quality - growth hormone is predominantly released during deep sleep; patients often report improved sleep architecture as one of the first effects
• Energy and vitality - general improvements in energy, motivation, and sense of wellbeing are commonly reported in longitudinal patient data

These uses are physician-supervised and treated as off-label clinical applications. They are not FDA-approved indications for CJC-1295 or Ipamorelin specifically.

What do clinical results look like?

Patients on CJC-1295/Ipamorelin combinations - when properly dosed under physician supervision - typically report:

• Improved sleep quality - often described within the first 2-4 weeks, particularly deeper sleep and more vivid dreams
• Gradual body composition changes - lean mass improvements and reduced body fat, typically becoming noticeable at 2-3 months of consistent use
• Recovery improvements - faster return to baseline after intense training or physical stress
• Skin and hair quality changes - some patients notice changes in skin thickness and hair texture over longer programs
• Energy improvements - reported by a significant subset of patients, often described as more sustained daily energy rather than a stimulant effect

Results vary substantially between individuals and are influenced by baseline GH levels, age, diet, sleep, and training habits.

What does a clinical program look like?

A physician-supervised GH secretagogue program typically involves:

1. 1Baseline labs - IGF-1 (the primary marker of GH activity), along with a comprehensive metabolic panel, hormone panel, and any condition-specific markers
2. 2A consultation with a prescribing physician - who reviews labs, health history, medications, and treatment goals before any prescription decision
3. 3Compounded injectable formulation - CJC-1295/Ipamorelin is almost always provided as a subcutaneous injection, compounded by a licensed US pharmacy
4. 4Dosing protocol - most programs start at low doses injected 5 days on, 2 days off or similar cycling patterns, typically in the evening before sleep to align with natural GH release
5. 5Follow-up IGF-1 testing - at 6-8 weeks to assess response and guide dose adjustments
6. 6Ongoing monitoring - quarterly labs and provider check-ins for active programs

The injection itself is subcutaneous (under the skin, typically in the abdomen) using a small insulin syringe. Most patients report minimal discomfort once they are comfortable with the process.

Is it legal in the US?

CJC-1295 and Ipamorelin are not FDA-approved drugs. This means they are not commercially manufactured or available at standard retail pharmacies. However, they can be legally prescribed by a licensed US physician and compounded by a licensed US compounding pharmacy under the Federal Food, Drug, and Cosmetic Act.

In 2024-2025, the FDA increased scrutiny of some compounded peptides - particularly BPC-157 and certain others. CJC-1295 and Ipamorelin have not been the primary target of these restrictions, and as of early 2026 remain available through licensed compounding pharmacies under valid physician prescriptions.

The key requirements are:

• A valid prescription from a US-licensed physician with prescribing authority
• A compounding pharmacy licensed under state pharmacy board and USP 797 standards
• Not purchased over-the-counter or from international online sellers

Purchasing peptides without a prescription - regardless of how they are labelled - falls outside the legal framework for medical use.

What to look for in a US clinic

When evaluating clinics for CJC-1295/Ipamorelin programs:

Physician involvement - look for a named prescribing physician, not just a "medical team." Someone with an MD, DO, or NP with prescribing authority should be the one reviewing your labs and signing off on the prescription.

Lab work before prescribing - a legitimate program will require an IGF-1 level at minimum. Clinics that prescribe without baseline labs are cutting corners.

Compounding pharmacy quality - ask which pharmacy compounds their peptides and whether they operate under USP 797 standards. Some clinics are transparent about this; others are not.

Follow-up monitoring - a good program includes scheduled follow-up labs and provider contact, not just a standing shipment.

Realistic expectations - be cautious of clinics making very aggressive claims. Results are real but gradual.

How to find a physician-supervised program

Use the Peptide Finder US directory to compare clinics offering growth hormone and longevity programs in your state. Filter by treatment goal or search for clinics in your city. Many programs are available via telehealth if no local clinic fits your needs.

State directories with GH peptide clinics: Texas - Florida - California - Colorado - Arizona - New York

Related guides: Sermorelin vs HGH: what to ask your doctor - Anti-aging peptides and longevity medicine - Peptide therapy for men

---

*This article is for educational purposes only. CJC-1295 and Ipamorelin require a valid prescription from a licensed US physician. Consult a qualified healthcare provider before starting any peptide program.*